176 related articles for article (PubMed ID: 9526995)
1. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme.
Canute GW; Longo SL; Longo JA; Shetler MM; Coyle TE; Winfield JA; Hahn PJ
Neurosurgery; 1998 Mar; 42(3):609-16. PubMed ID: 9526995
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea accelerates the loss of epidermal growth factor receptor genes amplified as double-minute chromosomes in human glioblastoma multiforme.
Canute GW; Longo SL; Longo JA; Winfield JA; Nevaldine BH; Hahn PJ
Neurosurgery; 1996 Nov; 39(5):976-83. PubMed ID: 8905754
[TBL] [Abstract][Full Text] [Related]
3. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of double minute chromosomes to hydroxyurea treatment in cultured methotrexate-resistant mouse cells.
Nevaldine BH; Rizwana R; Hahn PJ
Mutat Res; 1999 Aug; 406(2-4):55-62. PubMed ID: 10479722
[TBL] [Abstract][Full Text] [Related]
5. Coamplification on chromosomes 7p12-13 and 9q12-13 identified by reverse chromosome painting in a glioblastoma multiforme.
Fischer U; Wullich B; Sattler HP; Göttert E; Zang KD; Meese E
Hum Genet; 1994 Mar; 93(3):331-4. PubMed ID: 8125486
[TBL] [Abstract][Full Text] [Related]
6. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
[TBL] [Abstract][Full Text] [Related]
8. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
Yin D; Ogawa S; Kawamata N; Leiter A; Ham M; Li D; Doan NB; Said JW; Black KL; Phillip Koeffler H
Oncogene; 2013 Feb; 32(9):1155-63. PubMed ID: 22580610
[TBL] [Abstract][Full Text] [Related]
9. Subsets of glioblastoma multiforme defined by molecular genetic analysis.
von Deimling A; von Ammon K; Schoenfeld D; Wiestler OD; Seizinger BR; Louis DN
Brain Pathol; 1993 Jan; 3(1):19-26. PubMed ID: 8269081
[TBL] [Abstract][Full Text] [Related]
10. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.
Pandita A; Aldape KD; Zadeh G; Guha A; James CD
Genes Chromosomes Cancer; 2004 Jan; 39(1):29-36. PubMed ID: 14603439
[TBL] [Abstract][Full Text] [Related]
11. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.
Lopez-Gines C; Gil-Benso R; Ferrer-Luna R; Benito R; Serna E; Gonzalez-Darder J; Quilis V; Monleon D; Celda B; Cerdá-Nicolas M
Mod Pathol; 2010 Jun; 23(6):856-65. PubMed ID: 20305620
[TBL] [Abstract][Full Text] [Related]
12. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7727-31. PubMed ID: 8052651
[TBL] [Abstract][Full Text] [Related]
13. Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft.
Goike HM; Asplund AC; Pettersson EH; Liu L; Sanoudou D; Collins VP
J Neuropathol Exp Neurol; 1999 Jul; 58(7):697-701. PubMed ID: 10411339
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells.
Thomas C; Ely G; James CD; Jenkins R; Kastan M; Jedlicka A; Burger P; Wharen R
Acta Neuropathol; 2001 Jun; 101(6):605-15. PubMed ID: 11515790
[TBL] [Abstract][Full Text] [Related]
15. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe.
Joos S; Scherthan H; Speicher MR; Schlegel J; Cremer T; Lichter P
Hum Genet; 1993 Feb; 90(6):584-9. PubMed ID: 8383093
[TBL] [Abstract][Full Text] [Related]
16. The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor.
Klingler-Hoffmann M; Fodero-Tavoletti MT; Mishima K; Narita Y; Cavenee WK; Furnari FB; Huang HJ; Tiganis T
J Biol Chem; 2001 Dec; 276(49):46313-8. PubMed ID: 11514572
[TBL] [Abstract][Full Text] [Related]
17. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity.
Von Hoff DD; McGill JR; Forseth BJ; Davidson KK; Bradley TP; Van Devanter DR; Wahl GM
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8165-9. PubMed ID: 1518843
[TBL] [Abstract][Full Text] [Related]
18. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
[TBL] [Abstract][Full Text] [Related]
19. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
20. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis.
Hurtt MR; Moossy J; Donovan-Peluso M; Locker J
J Neuropathol Exp Neurol; 1992 Jan; 51(1):84-90. PubMed ID: 1311022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
